Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion
暂无分享,去创建一个
Y. Matsuda | Hidekazu Suzuki | F. Imamura | T. Hirashima | K. Katayama | M. Tamiya | A. Tamiya | S. Atagi | T. Kumagai | S. Minomo | K. Nakao | T. Shiroyama | N. Okamoto | Y. Taniguchi | Yujiro Naito | N. Takeuchi | K. Okishio